Home›Pramlintide›Legal status
Educational — Not Legal AdviceReviewed
Is Pramlintide legal? FDA status and US regulatory standing
Current status
FDA-approved. Pramlintide is an FDA-approved drug (status recorded ).
Primary source: www.accessdata.fda.gov
Federal legal status
FDA approval status
Pramlintide is an FDA-approved drug. FDA-approved amylin analog. Brand: Symlin (NDA 021332, Mar 2005). Adjunct to insulin therapy in T1D and T2D. Prescription only. Subcutaneous injection.
Also known as
Symlin · AC0137
Status history
- Pramlintide is an FDA-approved drug. [source]
Frequently asked questions
- Is Pramlintide FDA approved?
- Pramlintide is an FDA-approved drug (status recorded 2005-03-16). Primary source linked on this page.
- Can doctors prescribe Pramlintide?
- Pramlintide is listed as prescription-availability in the PeptideBase library. Prescribing rules vary by state and prescriber licensure — consult a licensed clinician.
PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.
Content review: Regulatory status is sourced from the linked primary records and reviewed by the PeptideBase editorial team. This page is educational — not legal or medical advice. Last reviewed: .